The C-Terminal Half of Heat Shock Protein 90 Represents a Second Site for Pharmacologic Intervention in Chaperone Function

By  

Current Cancer Drug Targets, Vol. 3, Iss. 5, 2003-10 ,pp. : 343-347

Bentham Science Publishers

Access to resources Recommend Favorite

The Heat Shock Protein 90 Chaperone Complex: An Evolving Therapeutic Target

By  

Current Cancer Drug Targets, Vol. 8, Iss. 6, 2008-09 ,pp. : 522-535

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment

By Patel Hardik J   Modi Shanu   Chiosis Gabriela   Taldone Tony  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 559-587

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics – an update

By Neckers Len   Neckers Katharine  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 137-149

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents

By Neckers Len   Neckers Katharine  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 277-288

Informa Healthcare

Access to resources Recommend Favorite